 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Materials Transfer Agreements Guidance for Investigators at Boston University & Boston Medical CenterWhat is a Materials Transfer Agreement (MTA)?An MTA is a contract that spells out the conditions under which one organization agrees to transfer to another organization tangible research materials for use in the recipient’s research program, excluding clinical trials. These materials include:
The MTA customarily defines the rights of the provider and the recipient in:
Why should your MTA be reviewed?All MTAs must be reviewed to ensure that the conditions imposed will not interfere with downstream rights of our investigator(s) or of our institution or impose unacceptable liabilities. MTAs with for-profit companies are particularly likely to require careful review and negotiation to protect your interests which may be counter to the commercial interests of companies. MTAs with other academic institutions and with Federal agencies are usually easier to finalize. MTAs with academic institutions often utilize the Uniform Biological Materials Transfer Agreement, to which many academic institutions are signatories. Where should you submit your MTA to be reviewed?In-coming Materials: Your MTA should be reviewed by: Medical Campus (BUSM, SPH, SDM)
Boston Medical Center
Charles River Campus
Out-going Materials: Your MTA should be reviewed by:
What important additional compliance responsibilities may be associated with your MTA?
|
|
 |
 |
 |
 |
| August 18, 2004 | Office of the Provost |